Science Explorer Back to mapMap
Discussion
Company · Beijing · ??

Euler Technology (China)

eulertechnology.comROR OpenAlex
Research works
16
▲ 180% vs 2018-21
Citations
159
10.1 per fractional work
Top-10% rate
28.2%
all institutions 10.0%
Open access
53%
world 40%
International
16%
world 18%
Euler Technology (China)

Not ranked overall: Euler Technology (China) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Euler Technology (China) work in?

In all years, 47% of research at Euler Technology (China) is in Physical Sciences, 24% in Life Sciences. Its largest fields are Engineering (40%), Biochemistry, Genetics and Molecular Biology (21%), Medicine (20%). It does 1.3× the world's share of Life Sciences.

Physical Sciences: 7 fractional works · 46.7% of its workEngineering: 6 fractional works · 40.3% of its workMechanical Engineering: 2 fractional works · 15.9% of its workMechanics of Materials: 1 fractional works · 8.5% of its workElectrical and Electronic Engineering: 1 fractional works · 5.3% of its workOcean Engineering: 1 fractional works · 4.3% of its workSafety, Risk, Reliability and Quality: 0 fractional works · 3.2% of its workAerospace Engineering: 0 fractional works · 2.1% of its workCivil and Structural Engineering: 0 fractional works · 1.1% of its workMaterials Science: 0 fractional works · 3.2% of its workMaterials Chemistry: 0 fractional works · 2.1% of its workGeneral Materials Science: 0 fractional works · 1.1% of its workComputer Science: 0 fractional works · 2.1% of its workArtificial Intelligence: 0 fractional works · 1.1% of its workComputer Vision and Pattern Recognition: 0 fractional works · 1.1% of its workEnvironmental Science: 0 fractional works · 1.1% of its workEnvironmental Engineering: 0 fractional works · 1.1% of its workLife Sciences: 4 fractional works · 24.5% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 20.8% of its workMolecular Biology: 2 fractional works · 11.1% of its workCancer Research: 1 fractional works · 4.7% of its workGenetics: 0 fractional works · 2.2% of its workCell Biology: 0 fractional works · 1.1% of its workBiochemistry: 0 fractional works · 1.0% of its workDevelopmental Biology: 0 fractional works · 0.7% of its workNeuroscience: 0 fractional works · 2.3% of its workCellular and Molecular Neuroscience: 0 fractional works · 1.0% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.8% of its workCognitive Neuroscience: 0 fractional works · 0.3% of its workSensory Systems: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.7% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.7% of its workImmunology and Microbiology: 0 fractional works · 0.7% of its workImmunology: 0 fractional works · 0.7% of its workHealth Sciences: 4 fractional works · 23.5% of its workMedicine: 3 fractional works · 20.3% of its workObstetrics and Gynecology: 1 fractional works · 6.9% of its workSurgery: 1 fractional works · 3.8% of its workEpidemiology: 0 fractional works · 2.0% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.3% of its workNeurology: 0 fractional works · 1.1% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.1% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.8% of its workGenetics: 0 fractional works · 0.7% of its workPhysiology: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.6% of its workUrology: 0 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.3% of its workOncology: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 3.2% of its workRadiological and Ultrasound Technology: 0 fractional works · 3.2% of its workSocial Sciences: 1 fractional works · 5.4% of its workDecision Sciences: 1 fractional works · 4.3% of its workStatistics, Probability and Uncertainty: 1 fractional works · 4.3% of its workPsychology: 0 fractional works · 1.1% of its workSocial Psychology: 0 fractional works · 1.1% of its workALL ITS WORKEuler Technology(China)16fractional works, all years
Life Sciences24%Physical Sciences47%Health Sciences24%Social Sciences5%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 12 fields, with their numbers
    1. Engineering640.3%
    2. Materials Science03.2%
    3. Computer Science02.1%
    4. Environmental Science01.1%
    1. Biochemistry, Genetics and Molecular Biology320.8%
    2. Neuroscience02.3%
    3. Agricultural and Biological Sciences00.7%
    4. Immunology and Microbiology00.7%
    1. Medicine320.3%
    2. Health Professions03.2%
    1. Decision Sciences14.3%
    2. Psychology01.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Who are the top researchers at Euler Technology (China)?

Ranked on the quality score, S. D. Lewis lead among researchers whose main affiliation is Euler Technology (China).

  1. 1 S. D. Lewis #5,052,449 worldwide 158 citations · 27 works
All ranked researchers at Euler Technology (China)

What are the most cited papers from Euler Technology (China)?

The most cited paper from Euler Technology (China) is "Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial" (Chang Chen, Yi Zhang, Jianying Huang et al., 2020), with 796 citations. Next come "Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial" (149) and "USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer" (79).

Most cited papers
#PaperReleasedCitations
1 Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial Chang Chen, Yi Zhang, Jianying Huang et al. · medRxiv PreprintOpen access 20 Mar 2020 796
2 Favipiravir Versus Arbidol for Clinical Recovery Rate in Moderate and Severe Adult COVID-19 Patients: A Prospective, Multicenter, Open-Label, Randomized Controlled Clinical Trial Chang Chen, Yi Zhang, Jianying Huang et al. · Frontiers in Pharmacology Open access 2 Sep 2021 149
3 USP43 stabilizes c-Myc to promote glycolysis and metastasis in bladder cancer Mingxing Li, Jingtian Yu, Lingao Ju et al. · Cell Death and Disease Open access 13 Jan 2024 79
4 Identification of autism-related MECP2 mutations by whole-exome sequencing and functional validation Wen Qiu Zhu, Tian‐Lin Cheng, Gaizhi Li et al. · Molecular Autism Open access 3 Aug 2017 72
5 UPP1 enhances bladder cancer progression and gemcitabine resistance through AKT Wenzhi Du, Sheng Tu, Wenxiu Zhang et al. · International Journal of Biological Sciences Open access 2024 51
All 56 most cited papers, with filters and sorting

Which research topics does Euler Technology (China) publish most on?

By volume in 2022-now: Pregnancy and preeclampsia studies, Epigenetics and DNA Methylation, Cancer, Lipids, and Metabolism and Ubiquitin and proteasome pathways.

Pregnancy and preeclamps…1Pregnancy and preeclampsia studies: 1 fractional worksEpigenetics and DNA Methylation: 0 fractional worksCancer, Lipids, and Metabolism: 0 fractional worksUbiquitin and proteasome pathways: 0 fractional worksBladder and Urothelial Cancer Treatments: 0 fractional worksFerroptosis and cancer prognosis: 0 fractional worksCancer, Hypoxia, and Metabolism: 0 fractional worksBat Biology and Ecology Studies: 0 fractional worksPhotoreceptor and optogenetics research: 0 fractional worksRNA modifications and cancer: 0 fractional works
Obstetrics and GynecologyMolecular BiologyCancer ResearchSurgery3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pregnancy and preeclampsia studies Obstetrics and Gynecology 1 works
  2. 2 Epigenetics and DNA Methylation Molecular Biology 0 works
  3. 3 Cancer, Lipids, and Metabolism Cancer Research 0 works
  4. 4 Ubiquitin and proteasome pathways Molecular Biology 0 works
  5. 5 Bladder and Urothelial Cancer Treatments Surgery 0 works
  6. 6 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 0 works
  7. 7 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  8. 8 Bat Biology and Ecology Studies Ecology, Evolution, Behavior and Systematics 0 works
  9. 9 Photoreceptor and optogenetics research Cellular and Molecular Neuroscience 0 works
  10. 10 RNA modifications and cancer Molecular Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.1%not open46.9%

World: 40% of research is openly available.

with international co-authors16.5%domestic only83.5%

World: 18% is written across borders.

How has Euler Technology (China)'s research output changed?

Output in 2022-2025 was 180% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Euler Technology (China) as a percentage of every work published that year, 0.000031% in 2024.

still counting0.000050%0.00010%0.00015%Euler Technology (China)0.0000082% in 202520102020

Fractional works of Euler Technology (China) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Beijing

All research institutions in Beijing

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Euler Technology (China). Posts are plain text and can be reported.